Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Venus Concept Inc. VERO

Venus Concept Inc is a medical technology company. It develops, commercializes and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies and related services. The company's products include NeoGraft, Venus Viva, Venus Legacy, Venus Versa, Venus Velocity, Venus Heal, Venus Bliss, ARTAS systems and others. The company provides medical devices and treatments for hair, body, and skin related problems. It operates in the U.S. as well as in other international countries.


Recent & Breaking News (NDAQ:VERO)

Venus Concept Receives 510(k) Clearance for Use of its AI.ME(TM) Next Generation Robotic Technology for Fractional Skin Resurfacing

GlobeNewswire December 21, 2022

Venus Concept Announces Completion of $6.72 Million Private Placement Financing

GlobeNewswire November 18, 2022

Venus Concept Announces Third Quarter of Fiscal Year 2022 Financial Results

GlobeNewswire November 10, 2022

Venus Concept Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire October 19, 2022

Venus Concept Appoints Dr. Hemanth Varghese as President & Chief Business Officer

GlobeNewswire October 11, 2022

Venus Concept Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire October 6, 2022

Venus Concept Announces Updated Release Date of November 10, 2022 for Third Quarter of Fiscal Year 2022 Financial Results

GlobeNewswire October 5, 2022

Venus Concept Announces Appointment of Rajiv De Silva as Chief Executive Officer and Director; Updates Fiscal Year 2022 Revenue Guidance

GlobeNewswire October 3, 2022

Venus Concept Announces Second Quarter of Fiscal Year 2022 Financial Results; Updates Fiscal Year 2022 Revenue Guidance

GlobeNewswire August 12, 2022

Venus Concept to Release Second Quarter of Fiscal Year 2022 Financial Results on August 12, 2022

GlobeNewswire June 30, 2022

Venus Concept Announces First Quarter of Fiscal Year 2022 Financial Results; Reaffirms Fiscal Year 2022 Revenue Guidance

GlobeNewswire May 12, 2022

Venus Concept Receives New FDA 510(k) Clearance for Venus BlissMAX

GlobeNewswire April 28, 2022

Venus Concept Announces First Patient Treatment in Study Evaluating the Safety and Efficacy of Aime(TM) Next Generation Robotic Technology for the Treatment of Moderate to Severe Facial Wrinkles

GlobeNewswire April 25, 2022

Venus Concept to Release First Quarter of Fiscal Year 2022 Financial Results on May 12, 2022

GlobeNewswire April 4, 2022

Venus Concept Submits FDA 510(k) Related to the Use of its Aime(TM) Next Generation Robotic Technology for Tissue Excision and Skin Resurfacing

GlobeNewswire March 31, 2022

Venus Concept Announces Fourth Quarter and Fiscal Year 2021 Financial Results; Introduces Fiscal Year 2022 Revenue Guidance

GlobeNewswire March 28, 2022

Venus Concept Inc. to Present at the Maxim Virtual Growth Conference on March 28th

GlobeNewswire March 21, 2022

Venus Concept Inc. to Participate in the BTIG Virtual MedTech, Digital Health, Life Science & Diagnostic Tools Conference on February 16th

GlobeNewswire February 8, 2022

Venus Concept to Release Fourth Quarter and Fiscal Year 2021 Financial Results on March 28, 2022

GlobeNewswire February 2, 2022

Venus Concept Receives FDA 510(k) Clearance of Venus BlissMAX for Non-Invasive Lipolysis of the Abdomen and Flanks, Cellulite Reduction and Muscle Conditioning

GlobeNewswire January 18, 2022